Basel, 15 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the cobas SARS-CoV-2 Duo for ...

by Roche Molecular Diagnostics The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche Molecular Diagnostics. The FDA has ...

reliable and accurate COVID-19 PCR testing beyond the EUA period. Based on continuous analysis performed since the onset of the pandemic, all Roche molecular tests, including the cobas SARS-CoV-2 ...

Developed by Roche scientists, the TAGS technology enhances PCR ... cobas Respiratory flex test is designed to detect and differentiate a range of respiratory viruses in nasopharyngeal swab ...

(RTTNews) - Roche Thursday announced the U.S ... serving as an early predictor of an impending infection. A urine sample stabilised in cobas PCR Media allows the integrity of urine results ...

The cobas Respiratory flex test can detect up to 12 of the most common respiratory viruses, including influenza A, influenza B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2, within a patient ...

Roche now offers a comprehensive testing solution allowing critical transplant testing (CMV, EBV, BKV) from a single sample ... cobas BKV are real-time PCR (polymerase chain reaction) tests with ...

New cobas(R) 4800 System designed to increase laboratory efficiency and medical value Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new Health Canada ...